Spectrum Medical


SARS-CoV-2 (Covid)

COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care settings.

Brands: Rapid Response, Fastep, BD, Artron, SD Bioscience, Boson and Lumos.
Additional brands are available upon request.

In stock



Detect SARS-CoV-2 antigens swiftly with COVID-19 Antigen Rapid Test Device. Qualitative in vitro assay for nasal samples within 6 days of symptoms. Authorized for Point of Care settings.

Your Content area

Our Covid-19 Screening Kit is designed to provide quick, accurate, and easy-to-interpret results within just 15 minutes, ensuring that you can take prompt action in managing health and safety. Our new Results+ platform has been integrated with this test to quickly and efficiently provide test results to your consumers on the spot!
• Identify nasal specimens with 90.2-95% accuracy.
• Obtain results in just 15 minutes.
• Identify the presence of SARS-COV-2.

Patient-Centric Services
Improve patient care by offering value added screening services in-store. Pharmacists can help address current backlogs within hospitals & clinics and minimize the strain on the Canadian healthcare system.

Digital Innovation with Results+
As healthcare delivery evolves and digital innovation persists, we want to help bridge the gap between medical device and software. Capture test images and print and/or email results with one click of a button!

Accuracy & Reliability
Excellent correlation to laboratory results. Quick, accurate & reliable results for enhanced healthcare.

Recommended products

Want to know more about Our Products?
Want to know more
about Our Products?

Find Out More!